Pathophysiology of Trauma-Induced Coagulopathy and Management of Critical Bleeding Requiring Massive Transfusion

Seminars in Thrombosis and Hemostasis

Volumn 42, Issue 2, 2015, Pages 155-165

  Gando, Satoshi ^a   Hayakawa, Mineji ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

blood products; coagulopathy; critical bleeding; disseminated intravascular coagulation; transfusion; trauma

Indexed keywords

FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ACIDOSIS; ACUTE COAGULOPATHY TRAUMA SHOCK; ANEMIA; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; DAMAGE CONTROL SURGERY; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; FIBRINOLYSIS; HEMODILUTION; HEMORRHAGIC SHOCK; HEMOSTATIC RESUSCITATION; HUMAN; HYPOTENSION; HYPOTHERMIA; INJURY; INTERNATIONAL NORMALIZED RATIO; META ANALYSIS (TOPIC); MICROVASCULATURE; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC CIRCULATION; TRAUMATIC SHOCK; BLOOD; COMPLICATION; DISSEMINATED INTRAVASCULAR COAGULATION; HEMORRHAGE; WOUNDS AND INJURIES;

DISSEMINATED INTRAVASCULAR COAGULATION; HEMORRHAGE; HUMANS; WOUNDS AND INJURIES;

EID: 84959176651     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0035-1564831     Document Type: Article

References (129)

1. Gando S., Sawamura A., Hayakawa M. Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg: 2011; 254 1 10 19
2. Spahn D. R., Bouillon B., Cerny V., et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care: 2013; 17 2 R76
3. Gando S., Otomo Y. Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock. Crit Care: 2015; 19 72
4. Gando S., Wada H., Kim H. K., et al. Scientific and Standardization Committee on DIC of the ISTH. Comparison of disseminated intravascular coagulation in trauma with coagulopathy of trauma/acute coagulopathy of trauma-shock. J Thromb Haemost: 2012; 10 12 2593 2595
5. Gando S., Wada H., Thachil J.; Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis (ISTH). Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS). J Thromb Haemost: 2013; 11 5 826 835
6. Shaz B. H., Winkler A. M., James A. B., Hillyer C. D., MacLeod J. B. Pathophysiology of early trauma-induced coagulopathy: emerging evidence for hemodilution and coagulation factor depletion. J Trauma: 2011; 70 6 1401 1407
7. Kaufmann C. R., Dwyer K. M., Crews J. D., Dols S. J., Trask A. L. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma: 1997; 42 4 716 720, discussion 720-722
8. Schreiber M. A., Differding J., Thorborg P., Mayberry J. C., Mullins R. J. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma: 2005; 58 3 475 480, discussion 480-481
9. Taylor F. B. Jr, Toh C. H., Hoots W. K., Wada H., Levi M.; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost: 2001; 86 5 1327 1330
10. Sawamura A., Hayakawa M., Gando S., et al. Application of the Japanese Association for Acute Medicine disseminated intravascular coagulation diagnostic criteria for patients at an early phase of trauma. Thromb Res: 2009; 124 6 706 710
11. Oshiro A., Yanagida Y., Gando S., Henzan N., Takahashi I., Makise H. Hemostasis during the early stages of trauma: comparison with disseminated intravascular coagulation. Crit Care: 2014; 18 2 R61
12. Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care: 2014; 2 1 20
13. Levi M. Disseminated intravascular coagulation. Crit Care Med: 2007; 35 9 2191 2195
14. Gando S. Hemostasis and thrombosis in trauma patients. Semin Thromb Hemost: 2015; 41 1 26 34
15. Manson J., Thiemermann C., Brohi K. Trauma alarmins as activators of damage-induced inflammation. Br J Surg: 2012; 99 01 12 20
16. Ito T. PAMPs and DAMPs as triggers for DIC. J Intensive Care: 2014; 2 1 67
17. Cohen M. J., Brohi K., Calfee C. S., et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care: 2009; 13 6 R174
18. Kutcher M. E., Xu J., Vilardi R. F., Ho C., Esmon C. T., Cohen M. J. Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C. J Trauma Acute Care Surg: 2012; 73 6 1389 1394
19. Abrams S. T., Zhang N., Manson J., et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med: 2013; 187 2 160 169
20. Zhang Q., Raoof M., Chen Y., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature: 2010; 464 7285 104 107
21. Fuchs T. A., Bhandari A. A., Wagner D. D. Histones induce rapid and profound thrombocytopenia in mice. Blood: 2011; 118 13 3708 3714
22. Semeraro F., Ammollo C. T., Morrissey J. H., et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood: 2011; 118 7 1952 1961
23. Ammollo C. T., Semeraro F., Xu J., Esmon N. L., Esmon C. T. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost: 2011; 9 9 1795 1803
24. Ito T., Kawahara K., Nakamura T., et al. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost: 2007; 5 1 109 116
25. Gando S., Nakanishi Y., Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med: 1995; 23 11 1835 1842
26. Lenz A., Franklin G. A., Cheadle W. G. Systemic inflammation after trauma. Injury: 2007; 38 12 1336 1345
27. Esmon C. T. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. Best Pract Res Clin Haematol: 1999; 12 3 343 359
28. Armstead V. E., Opentanova I. L., Minchenko A. G., Lefer A. M. Tissue factor expression in vital organs during murine traumatic shock: role of transcription factors AP-1 and NF-kappaB. Anesthesiology: 1999; 91 6 1844 1852
29. Dunbar N. M., Chandler W. L. Thrombin generation in trauma patients. Transfusion: 2009; 49 12 2652 2660
30. Chandler W. L. Procoagulant activity in trauma patients. Am J Clin Pathol: 2010; 134 1 90 96
31. Ishii H., Majerus P. W. Thrombomodulin is present in human plasma and urine. J Clin Invest: 1985; 76 6 2178 2181
32. Ishii H., Uchiyama H., Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost: 1991; 65 5 618 623
33. Boehme M. WJ, Deng Y., Raeth U., et al. Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology: 1996; 87 1 134 140
34. Gando S., Nanzaki S., Morimoto Y., Ishitani T., Kemmotsu O. Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients. Crit Care Med: 2001; 29 2 262 266
35. Taylor F., Chang A., Ferrell G., et al. C4b-binding protein exacerbates the host response to Escherichia coli. Blood: 1991; 78 2 357 363
36. Engelman D. T., Gabram S. GA, Allen L., Ens G. E., Jacobs L. M. Hypercoagulability following multiple trauma. World J Surg: 1996; 20 1 5 10
37. Gando S., Nakanishi Y., Kameue T., Nanzaki S. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase. J Trauma: 1995; 39 4 660 664
38. Gando S., Kameue T., Matsuda N., et al. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb Haemost: 2002; 88 6 943 949
39. Yanagida Y., Gando S., Sawamura A., et al. Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: comparison with acute coagulopathy of trauma-shock. Surgery: 2013; 154 1 48 57
40. Gando S., Tedo I., Kubota M. Posttrauma coagulation and fibrinolysis. Crit Care Med: 1992; 20 5 594 600
41. Marder V. J., Feinstein D. I., Colman R. W., Levi M. Consumptive thrombohemorrhagic disorders. In: Colman R. W., Marder V. J., Clowes A. W., George J. N., Goldhaber S. Z. eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 5th ed. Philadelphia, PA Lippincott Williams & Wilkins: 2006; 1571 1600
42. Lowenstein C. J., Morrell C. N., Yamakuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med: 2005; 15 8 302 308
43. Stump D. C., Taylor F. B. Jr, Nesheim M. E., Giles A. R., Dzik W. H., Bovill E. G. Pathologic fibrinolysis as a cause of clinical bleeding. Semin Thromb Hemost: 1990; 16 3 260 273
44. Suffredini A. F., Harpel P. C., Parrillo J. E. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med: 1989; 320 18 1165 1172
45. Levi M., ten Cate H., van der Poll T., van Deventer S. J. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA: 1993; 270 8 975 979
46. Gando S., Kameue T., Nanzaki S., Nakanishi Y. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost: 1997; 77 2 278 282
47. Hayakawa M., Sawamura A., Gando S., et al. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase. Surgery: 2011; 149 2 221 230
48. Gando S., Makise H., Tedo I. [Gaisyogo no sosyochiyu insi]. Nippon Geka Gakkai Zasshi: 1990; 91 1 17 22
49. Giles A. R., Nesheim M. E., Mann K. G. Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation. J Clin Invest: 1984; 74 6 2219 2225
50. Wyshock E. G., Suffredini A. F., Parrillo J. E., Colman R. W. Cofactors V and VIII after endotoxin administration to human volunteers. Thromb Res: 1995; 80 5 377 389
51. Sawamura A., Hayakawa M., Gando S., et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res: 2009; 124 5 608 613
52. Brohi K., Cohen M. J., Ganter M. T., Matthay M. A., Mackersie R. C., Pittet J. F. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg: 2007; 245 5 812 818
53. Brohi K., Cohen M. J., Ganter M. T., et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma: 2008; 64 5 1211 1217, discussion 1217
54. Hess J. R., Brohi K., Dutton R. P., et al. The coagulopathy of trauma: a review of mechanisms. J Trauma: 2008; 65 4 748 754
55. Davenport R. Pathogenesis of acute traumatic coagulopathy. Transfusion: 2013; 53 01 23S 27S
56. Brohi K., Cohen M. J., Davenport R. A. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care: 2007; 13 6 680 685
57. Johansson P. I., Stensballe J., Rasmussen L. S., Ostrowski S. R. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg: 2011; 254 2 194 200
58. Noel P., Cashen S., Patel B. Trauma-induced coagulopathy: from biology to therapy. Semin Hematol: 2013; 50 3 259 269
59. Maegele M., Schöchl H., Cohen M. J. An update on the coagulopathy of trauma. Shock: 2014; 41 01 21 25
60. Valeri C. R., Khuri S., Ragno G. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins. Transfusion: 2007; 47 (4, Suppl): 206S 248S
61. Escolar G., Garrido M., Mazzara R., Castillo R., Ordinas A. Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion: 1988; 28 5 406 411
62. Eugster M., Reinhart W. H. The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost: 2005; 94 6 1213 1218
63. Blajchman M. A., Bordin J. O., Bardossy L., Heddle N. M. The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals. Br J Haematol: 1994; 86 2 347 350
64. Peyrou V., Lormeau J. C., Hérault J. P., Gaich C., Pfliegger A. M., Herbert J. M. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost: 1999; 81 3 400 406
65. Santos M. T., Valles J., Marcus A. J., et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest: 1991; 87 2 571 580
66. Santos M. T., Valles J., Aznar J., Marcus A. J., Broekman M. J., Safier L. B. Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin. Circulation: 1997; 95 1 63 68
67. Valeri C. R., Cassidy G., Pivacek L. E., et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion: 2001; 41 8 977 983
68. Iwata H., Kaibara M. Activation of factor IX by erythrocyte membranes causes intrinsic coagulation. Blood Coagul Fibrinolysis: 2002; 13 6 489 496
69. Iwata H., Kaibara M., Dohmae N., Takio K., Himeno R., Kawakami S. Purification, identification, and characterization of elastase on erythrocyte membrane as factor IX-activating enzyme. Biochem Biophys Res Commun: 2004; 316 1 65 70
70. Kaibara M., Iwata H., Ujiie H., Himeno R., Kaibara M. Rheological analyses of coagulation of blood from different individuals with special reference to procoagulant activity of erythrocytes. Blood Coagul Fibrinolysis: 2005; 16 5 355 363
71. Quaknine-Orlando B., Samama C. M., Riou B., et al. Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology: 1999; 90 5 1454 1461
72. Martini W. Z., Pusateri A. E., Uscilowicz J. M., Delgado A. V., Holcomb J. B. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma: 2005; 58 5 1002 1009, discussion 1009-1010
73. Martini W. Z. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma: 2009; 67 1 202 208, discussion 208-209
74. Wolberg A. S., Meng Z. H., Monroe D. M. III, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma: 2004; 56 6 1221 1228
75. Ho A. M., Karmakar M. K., Dion P. W. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg: 2005; 190 3 479 484
76. Wada H., Thachil J., Di Nisio M., et al. The Scientific and Standardization Committee on DIC of the ISTH. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. J Thromb Haemost: 2013; 11 761 767
77. Shakur H., Roberts I., Bautista R., et al. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet: 2010; 376 9734 23 32
78. Roberts I., Shakur H., Afolabi A., et al. CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet: 2011; 377 9771 1096 1101, 1101.e1-1101.e2
79. Gando S. Disseminated intravascular coagulation. In: Gonzalez E., Moore E. B., Moore E. E. eds. Trauma-Induced Coagulopathy. New York, NY Springer: 2015; (in press)
80. Duchesne J. C., McSwain N. E. Jr, Cotton B. A., et al. Damage control resuscitation: the new face of damage control. J Trauma: 2010; 69 4 976 990
81. Pohlman T. H., Walsh M., Aversa J., Hutchison E. M., Olsen K. P., Lawrence Reed R. Damage control resuscitation. Blood Rev: 2015; 29 4 251 262
82. Jansen J. O., Thomas R., Loudon M. A., Brooks A. Damage control resuscitation for patients with major trauma. BMJ: 2009; 338 b1778
83. Jaunoo S. S., Harji D. P. Damage control surgery. Int J Surg: 2009; 7 2 110 113
84. Bickell W. H., Wall M. J. Jr, Pepe P. E., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med: 1994; 331 17 1105 1109
85. Kwan I., Bunn F., Roberts I.; WHO Pre-Hospital Trauma Care Steering Committee. Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev: 2003; 3 3 CD002245
86. Berry C., Ley E. J., Bukur M., et al. Redefining hypotension in traumatic brain injury. Injury: 2012; 43 11 1833 1837
87. Pham H. P., Shaz B. H. Update on massive transfusion. Br J Anaesth: 2013; 111 01 i71 i82
88. Waters J. H. Role of the massive transfusion protocol in the management of haemorrhagic shock. Br J Anaesth: 2014; 113 02 ii3 ii8
89. Dzik W. H., Blajchman M. A., Fergusson D., et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel. Crit Care: 2011; 15 6 242
90. Curry N., Stanworth S., Hopewell S., Dorée C., Brohi K., Hyde C. Trauma-induced coagulopathy - a review of the systematic reviews: is there sufficient evidence to guide clinical transfusion practice? Transfus Med Rev: 2011; 25 3 217 231.e2
91. McQuilten Z. K., Crighton G., Engelbrecht S., et al. Transfusion interventions in critical bleeding requiring massive transfusion: a systematic review. Transfus Med Rev: 2015; 29 2 127 137
92. Schöchl H., Maegele M., Solomon C., Görlinger K., Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med: 2012; 20 15
93. Holcomb J. B., Minei K. M., Scerbo M. L., et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg: 2012; 256 3 476 486
94. Khan S., Brohi K., Chana M., et al. International Trauma Research Network (INTRN). Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg: 2014; 76 3 561 567, discussion 567-568
95. Chitlur M., Sorensen B., Rivard G. E., et al. Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia: 2011; 17 3 532 537
96. Afshari A., Wikkelsø A., Brok J., Møller A. M., Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. [Review] Cochrane Database Syst Rev: 2011; 3 3 CD007871
97. Da Luz L. T., Nascimento B., Shankarakutty A. K., Rizoli S., Adhikari N. K. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care: 2014; 18 5 518
98. Hunt H., Stanworth S., Curry N., et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. [Review] Cochrane Database Syst Rev: 2015; 2 CD010438
99. Borgman M. A., Spinella P. C., Perkins J. G., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma: 2007; 63 4 805 813
100. Ho A. M., Dion P. W., Yeung J. HH., et al. Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology: 2012; 116 3 716 728
101. Stansbury L. G., Dutton R. P., Stein D. M., Bochicchio G. V., Scalea T. M., Hess J. R. Controversy in trauma resuscitation: do ratios of plasma to red blood cells matter? Transfus Med Rev: 2009; 23 4 255 265
102. Phan H. H., Wisner D. H. Should we increase the ratio of plasma/platelets to red blood cells in massive transfusion: what is the evidence? Vox Sang: 2010; 98 3, Pt 2 395 402
103. Curry N., Hopewell S., Dorée C., Hyde C., Brohi K., Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care: 2011; 15 2 R92
104. Hallet J., Lauzier F., Mailloux O., et al. The use of higher platelet: RBC transfusion ratio in the acute phase of trauma resuscitation: a systematic review. Crit Care Med: 2013; 41 12 2800 2811
105. Murad M. H., Stubbs J. R., Gandhi M. J., et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion: 2010; 50 6 1370 1383
106. Johansson P. I., Oliveri R. S., Ostrowski S. R. Hemostatic resuscitation with plasma and platelets in trauma. J Emerg Trauma Shock: 2012; 5 2 120 125
107. National Blood Authority Australia. Patient blood management guidelines: Module 1, Critical bleeding/massive transfusion. 2011;. Available at: http://www.blood.gov.au/pbm-module-1. Accessed May 14, 2015
108. Holcomb J. B., del Junco D. J., Fox E. E., et al. PROMMTT Study Group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg: 2013; 148 2 127 136
109. del Junco D. J., Holcomb J. B., Fox E. E., et al. PROMMTT Study Group. Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg: 2013; 75 1 01 S24 S30
110. Holcomb J. B., Tilley B. C., Baraniuk S., et al. PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA: 2015; 313 5 471 482
111. Cotton B. A., Podbielski J., Camp E., et al. Early Whole Blood Investigators. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg: 2013; 258 4 527 532, discussion 532-533
112. Hayakawa M., Gando S., Ono Y., Wada T., Yanagida Y., Sawamura A. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. Semin Thromb Hemost: 2015; 41 1 35 42
113. Levy J. H., Welsby I., Goodnough L. T. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion: 2014; 54 5 1389 1405, quiz 1388
114. Warmuth M., Mad P., Wild C. Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand: 2012; 56 5 539 548
115. Wikkelsø A., Lunde J., Johansen M., et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev: 2013; 8 CD008864
116. Kozek-Langenecker S., Sørensen B., Hess J. R., Spahn D. R. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care: 2011; 15 5 R239
117. Meyer M. AS, Ostrowski S. R., Windeløv N. A., Johansson P. I. Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang: 2011; 101 3 185 190
118. Aubron C., Reade M. C., Fraser J. F., Cooper D. J. Efficacy and safety of fibrinogen concentrate in trauma patients - a systematic review. J Crit Care: 2014; 29 3 471.e11 471.e17
119. Grottke O., Rossaint R., Henskens Y., van Oerle R., Ten Cate H., Spronk H. MH. Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model. PLoS ONE: 2013; 8 5 e64100
120. Ferreira J., DeLosSantos M. The clinical use of prothrombin complex concentrate. J Emerg Med: 2013; 44 6 1201 1210
121. Matsushima K., Benjamin E., Demetriades D. Prothrombin complex concentrate in trauma patients. Am J Surg: 2015; 209 2 413 417
122. Innerhofer P., Westermann I., Tauber H., et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury: 2013; 44 2 209 216
123. Schöchl H., Voelckel W., Maegele M., Kirchmair L., Schlimp C. J. Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care: 2014; 18 4 R147
124. Grundman C., Plesker R., Kusch M., et al. Prothrombin overload causes thromboembolic complications in prothrombin complex concentrates: in vitro and in vivo evidence. Thromb Haemost: 2005; 94 6 1338 1339
125. Grottke O., Braunschweig T., Spronk H. MH., et al. Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood: 2011; 118 7 1943 1951
126. Boffard K. D., Riou B., Warren B., et al. NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma: 2005; 59 1 8 15, discussion 15-18
127. Hauser C. J., Boffard K., Dutton R., et al. CONTROL Study Group. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma: 2010; 69 3 489 500
128. Simpson E., Lin Y., Stanworth S., Birchall J., Doree C., Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. (Review) Cochrane Database Syst Rev: 2012; 3 CD005011
129. Fourrier F. Severe sepsis, coagulation, and fibrinolysis: dead end or one way? Crit Care Med: 2012; 40 9 2704 2708